Korea Investment Partners Puts $2 Million Into US Biotech HexemBio
KIP invested USD 2 million in HexemBio via the KIPUS Trinitas Fund, lifting the Draper-backed stem cell startup's total funding to USD 15.5 million as it seeks Korean pharma partnerships.